Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profitability Rebound ⢠Cash-Rich Balance Sheet ⢠Heavy Liability Load HNGE's latest quarter shows strong gross margins, positive operating/net income, and robust cash generation, but the stock still carries a heavy liability load, substantial share-based compensation, and a pricey valuation.
Price Behavior
Key Price Behavior Insights: ⢠Higher-low base ⢠Resistance test ⢠Fast rebound Support Level: $79.00-$80.00 Resistance Level: $89.00-$90.00 HNGE has improved over the last month with a sharp rebound and higher lows, but it remains stretched into $89-$90 resistance and needs a decisive breakout to confirm a more durable uptrend.
Sentiment & News
Key News Insights: ⢠Revenue surge ⢠Margin improvement ⢠Care expansion Hinge Health is showing strong revenue growth, improving profitability, and expanding care offerings, but the stock's sharp pre-results rally and earlier valuation concerns suggest upside may now depend on sustained execution.
AI Summary
HNGE is shifting from a âgrowth at all costsâ story to a scaled, cash-generative operating model, with Q2 showing 53% revenue growth, 29% operating margin, and $100M FCF, but the key question now is whether that profitability is durable as it integrates Cylinder Health and expands into GI care; the stock's re-rating means execution and margin sustainmentânot revenue aloneâwill determine upside from here.
Description
Hinge Health develops software for musculoskeletal care, providing digital programs and services that support treatment of acute injuries, chronic pain and post-operative rehabilitation. The company also offers administrative and operational support to health plans and employers. Founded in 2012, it is headquartered in San Francisco, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 17 | Jun 24 | HNGE | Hinge Health, Inc. | Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment. | Closed | +5.3% |
| May 14 | May 21 | HNGE | Hinge Health, Inc. | Healthcare momentum candidate with strong execution: Q1 revenue was $182M, up 47% YoY and ahead of expectations, margins improved, management raised full-year revenue guidance, and Q1 free cash flow was $41.6M. Stock is up about 25% over the last 21 trading days with only a modest pullback from its recent high. | Closed | +2.3% |